3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
2
Myocardial Reperfusion Injury
2
Cardiotoxicity
2
Vomiting
1
Uveal Melanoma
1
Thrombosis
1
Substance Withdrawal Syndrome
1
Retinal Diseases
1
Reperfusion Injury
1
Pain, Postoperative
1
Opioid-Related Disorders
1
Nausea
1
Melanoma
1
Macular Degeneration
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Choroid Diseases
1
Breast Neoplasms
1
Interventions
Standard of Care
2
salicylhydroxamic acid
1
methylnaltrexone
1
acetaminophen, codeine drug combination
1
X-Rays
1
Ultrasonic Waves
1
Tramadol
1
Tirzepatide
1
Therapeutics
1
Sublocade
1
Radiography, Abdominal
1
Psilocybin
1
Olanzapine
1
Morphine
1
Midazolam
1
Methadone
1
Medical Marijuana
1
Lidocaine
1
Hematologic Tests
1
Educational Status
1
Dosage Forms
1
Capsules
1
Buprenorphine, Naloxone Drug Combination
1
Buprenorphine
1
Blood Specimen Collection
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Opioid-Related Disorders
×
salicylhydroxamic acid
×
Clear all
NCT04850664
2021-08-06
CBOT-OUD
Evon Medics LLC
Phase 2
Unknown
190 enrolled